842PCTC-based biomarkers & PSMA-targeted imaging in patients with metastatic castrate-resistant prostate cancer (mCRPC). (23rd October 2018) - Morris, M J; Vogelzang, N J; Sartor, O; Armour, A; Messmann, R; Groaning, M; Robarts, A; Tolcher, A W; Gordon, M; Babiker, H M; Kuo, P; Kearney, M; et al.